TINA WINTER: Open Payments
NPI 1922676675 · MARYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 49 payments from 14 companies in 2025. Trend: 2023 $853 · 2024 $814 · 2025 $908
Food & beverage: $869Education: $39
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $189 |
| Novo Nordisk Inc | 8 | $146 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Amgen Inc. | 5 | $90 |
| Lilly USA, LLC | 3 | $62 |
| ABBVIE INC. | 3 | $55 |
| Lundbeck LLC | 2 | $53 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
Products named: AIRSUPRA, Rybelsus, MOUNJARO, TRELEGY ELLIPTA, BREZTRI, REXULTI, GVOKE HYPOPEN, AREXVY.
Industry payments across IL — which companies pay providers there.
